Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-6-15
pubmed:abstractText
Cathepsin L is a cysteine protease that can generate endogenous endostatin in vascular and epithelial basement membranes and importantly participates in a variety of pathophysiological processes. The present study was designed to determine whether this cathepsin L-derived endogenous endostatin alters endothelium-dependent vasodilator responses in coronary arteries via NAD(P)H oxidase activation. In isolated and perfused small bovine coronary arteries, administration of cathepsin L (200 ng/ml) markedly attenuated endothelium-dependent vasodilator responses to bradykinin or A23187 by 56.16+/-9.58% and 68.95+/-10.32%, respectively. This inhibitory effect of cathepsin L on endothelium-dependent vasodilator responses could be significantly reversed by pre-incubation of the arteries with O(2)(-) scavenger, Tiron, or neutralizing anti-endostatin antibody. By fluorescent ELISA assay, cathepsin L dose-dependently increased endostatin production in coronary arteries. In situ high-speed dual wavelength switching fluorescent microscopic imaging showed that cathepsin L decreased bradykinin- and A23187-induced NO levels in the intact endothelium, but it had no effect on Ca(2+) response to these vasodilators. This cathepsin L-induced reduction of NO was restored by the pretreatment of an anti-endostatin antibody. Electron spin resonance (ESR) analysis demonstrated that cathepsin L increased O(2)(-) production which could be markedly attenuated by the NAD(P)H oxidase inhibitors, apocynin or anti-endostatin antibody. It is concluded that endostatin could be endogenously produced in coronary arteries when cathepsin L is increased and that this cathepsin L-derived endostatin, if excessive, may result in endothelial dysfunction through enhanced production of O(2)(-) due to NAD(P)H oxidase activation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-10206987, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-10329390, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-10455063, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-10642331, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-10716919, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-11073878, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-11451740, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-11498076, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-11959628, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-11978735, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-12388315, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-12437086, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-14685281, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-15020207, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-15255178, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-15313955, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-15471985, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-15995169, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-16344372, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-16427865, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-16473958, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-16502253, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-1703045, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-17404153, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-18162606, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-18207366, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-18772496, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-3838314, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-8188291, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-9008168, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-9389480, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-9545226, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-9666719, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-9687493, http://linkedlifedata.com/resource/pubmed/commentcorrection/19345232-9811821
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1095-9319
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
78
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
45-50
pubmed:dateRevised
2010-12-28
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Dependence of cathepsin L-induced coronary endothelial dysfunction upon activation of NAD(P)H oxidase.
pubmed:affiliation
Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, 410 N 12th, Richmond, VA 23298, USA.
pubmed:publicationType
Journal Article